Pneumococcal Disease News and Research

RSS

Pneumococcal disease describes a group of illnesses caused by the bacterium Streptococcus pneumoniae, also known as pneumococcus. This bacterial pathogen, which affects both children and adults, is a major cause of death and illness worldwide. In fact, according to the World Health Organization (WHO), pneumococcal disease is the number one vaccine-preventable cause of death in children younger than 5 years of age worldwide.

Recommending adults to get pneumococcal vaccine at age 50 may be effective guidance

If mitigating racial disparities in those who contract pneumococcal diseases, such as meningitis and pneumonia, is a top public health priority, then recommending that all adults get a pneumococcal vaccine at age 50 would likely be effective guidance, according to a University of Pittsburgh School of Medicine analysis published today in the journal Vaccine.

4 Mar 2019

Pfizer’s 20vPnC vaccine receives Breakthrough Therapy designation from FDA

Pfizer Inc. announced today that its 20-Valent Pneumococcal Conjugate Vaccine candidate, PF-06482077, received Breakthrough Therapy designation from the US Food and Drug Administration for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes in the vaccine in adults aged 18 years and older. Pfizer expects to start Phase 3 trials in a few months.

20 Sep 2018

Pneumococcal genes predict course of disease

Pneumococcus is an important cause of pneumonia, sepsis and meningitis. This bacterium commonly resides in the nasal cavity.

6 Jul 2018

New vaccine for pneumonia holds promise to save thousands of lives

In 2004, pneumonia killed more than 2 million children worldwide, according to the World Health Organization. By 2015, the number was less than 1 million.

20 Oct 2017

Survey finds parents to be least knowledgeable about invasive pneumococcal disease

Pfizer Inc., in partnership with Parents magazine, announced today the results of a national survey of more than 2,000 new and expectant parents assessing their knowledge of childhood infectious diseases, such as measles, whooping cough and invasive pneumococcal disease, and the measures parents can take to help prevent them.

14 Jun 2017

Important vaccines that should not be missed by adults, elders and pregnant women

Vaccines are an important part of routine healthcare for adults, seniors and women who are pregnant.

16 Jan 2017

School holidays may be linked to increased rates of adult pneumococcal CAP

A study presented today (6 September 2016) at this year's European Respiratory Society International Congress in London, UK shows that adults admitted to hospital during school holidays are 38% more likely to have pneumococcal community-acquired pneumonia (CAP) than those admitted during term time.

6 Sep 2016

Researchers design E. coli-based transport capsule to help fight pneumococcal disease

Most people recoil at the thought of ingesting E. coli. But what if the headline-grabbing bacteria could be used to fight disease?

4 Jul 2016

Oxford researchers discover genes that make children more susceptible to bacteraemia

A team led by Oxford University has identified genes that make certain children more susceptible to invasive bacterial infections by performing a large genome-wide association study in African children.

27 May 2016

Scientists create detailed image of deadly toxin linked to bacterial pneumonia, meningitis, septicaemia

Scientists from the University of Leicester have for the first time created a detailed image of a toxin - called pneumolysin - associated with deadly infections such as bacterial pneumonia, meningitis and septicaemia.

25 Nov 2015

ACP awarded $1,002,884 Cooperative Agreement to increase adult immunization rates in US

The American College of Physicians (ACP) was awarded a $1,002,884 Cooperative Agreement from the Centers for Disease Control and Prevention (CDC) to increase immunization rates in the United States.

16 Sep 2015

Pneumococcal vaccine prevents illness, reduces severe antibiotic-resistant infections in young children

The pneumococcal vaccine recommended for young children not only prevents illness and death, but also has dramatically reduced severe antibiotic-resistant infections, suggests nationwide research being presented at IDWeek 2014.

12 Oct 2014

CDC urges all adults to get flu vaccination

Influenza vaccination coverage estimates show an encouraging upward trend overall, but coverage among healthy 18 to 64 year-olds has yet to top 40 percent, according to new data announced at a news conference held today by the National Foundation for Infectious Diseases.

19 Sep 2014

Chinese study of serogroup 6 S. pneumoniae finds no antibiotic-resistant clones

A survey of serogroup 6 Streptococcus pneumoniae isolates from children in China has identified no antibiotic-resistant clones, leading the authors to speculate that the isolates may be under antibiotic selective pressure.

8 Sep 2014

‘Concerning’ rise in pneumococcus risk factors

Researchers report that the incidence of Streptococcus pneumoniae infection has fallen significantly in the USA in the past decade but describe a “concerning trend” whereby the baseline health status of those with serious pneumococcal disease has worsened.

1 Sep 2014

Pneumococcal Disease News and Research

Recommending adults to get pneumococcal vaccine at age 50 may be effective guidance

Pfizer’s 20vPnC vaccine receives Breakthrough Therapy designation from FDA

Pneumococcal genes predict course of disease

New vaccine for pneumonia holds promise to save thousands of lives

Survey finds parents to be least knowledgeable about invasive pneumococcal disease

Important vaccines that should not be missed by adults, elders and pregnant women

School holidays may be linked to increased rates of adult pneumococcal CAP

Researchers design E. coli-based transport capsule to help fight pneumococcal disease

Oxford researchers discover genes that make children more susceptible to bacteraemia

Scientists create detailed image of deadly toxin linked to bacterial pneumonia, meningitis, septicaemia

ACP awarded $1,002,884 Cooperative Agreement to increase adult immunization rates in US

Pneumococcal vaccine prevents illness, reduces severe antibiotic-resistant infections in young children

CDC urges all adults to get flu vaccination

Chinese study of serogroup 6 S. pneumoniae finds no antibiotic-resistant clones

‘Concerning’ rise in pneumococcus risk factors

High uptake of US infant vaccination in 2013

Canadian invasive pneumococcal disease outbreak characterised

Contemporary dataset reveals burden of paediatric pneumococcal disease

Current smoking heralds worse outcomes in pneumococcal CAP

Hypervirulent S. pneumoniae mutants discovered

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News